Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free MVSTW Stock Alerts

Microvast (MVSTW) Financials

Microvast logo
$0.0085 0.00 (0.00%)
As of 06/12/2026 03:45 PM Eastern
Compare
Annual Income Statements for Microvast

Annual Income Statements for Microvast

This table shows Microvast's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -100 -81 -225 -158 -106 -195
Consolidated Net Income / (Loss)		 -60 -34 -206 -158 -106 -195
Net Income / (Loss) Continuing Operations		 -60 -34 -206 -158 -106 -195
Total Pre-Tax Income 		-59 -34 -206 -158 -106 -195
Total Revenue		 70 102 153 204 308 380
Net Interest Income / (Expense)		 -6.35 -5.17 -4.97 -0.14 0.98 -8.97
Total Interest Income		 0.00 0.57 0.45 3.18 3.61 0.74
Investment Securities Interest Income		 - 0.57 0.45 3.18 3.61 0.74
Total Interest Expense		 6.35 5.74 5.41 3.32 2.63 9.71
Long-Term Debt Interest Expense		 6.35 5.74 5.41 3.32 2.63 9.71
Total Non-Interest Income		 76 108 158 204 307 389
Net Realized & Unrealized Capital Gains on Investments		 - - - 0.00 0.00 9.41
Other Non-Interest Income		 76 108 158 204 307 380
Total Non-Interest Expense		 130 136 360 363 413 576
Marketing Expense		 42 30 56 66 69 64
Other Operating Expenses		 92 109 296 298 346 342
Impairment Charge		 - - - 1.80 0.50 93
Other Special Charges		 -3.24 -3.65 7.39 -2.65 -2.01 77
Income Tax Expense		 0.19 0.00 0.00 0.03 0.01 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 - 16 0.00 0.00 -0.08 0.00
Basic Earnings per Share		 ($1.17) ($0.82) ($1.26) ($0.52) ($0.34) ($0.61)
Weighted Average Basic Shares Outstanding		 99.03M 99.03M 185.90M 303.28M 310.91M 318.46M
Diluted Earnings per Share		 ($1.17) ($0.82) ($1.26) ($0.52) ($0.34) ($0.61)
Weighted Average Diluted Shares Outstanding		 99.03M 99.03M 185.90M 303.28M 310.91M 318.46M
Weighted Average Basic & Diluted Shares Outstanding		 99.03M 99.03M 185.90M 309.41M 317.21M 325.21M

Quarterly Income Statements for Microvast

This table shows Microvast's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -30 -26 -26 -25 -25 -102 13 -82 62 -106 -1.49
Consolidated Net Income / (Loss)		 -30 -26 -26 -25 -25 -102 13 -82 62 -106 -1.49
Net Income / (Loss) Continuing Operations		 -30 -26 -26 -25 -25 -102 13 -82 62 -106 -1.49
Total Pre-Tax Income 		-30 -26 -26 -25 -25 -102 13 -82 62 -106 -0.75
Total Revenue		 48 76 80 104 80 82 105 121 116 91 122
Net Interest Income / (Expense)		 0.92 1.03 0.09 -1.06 -1.61 -1.85 -4.10 -1.40 -1.01 -1.05 -1.02
Total Interest Income		 1.38 1.52 0.58 0.13 0.12 0.25 0.19 0.19 0.18 0.20 0.24
Investment Securities Interest Income		 1.38 1.52 0.58 0.13 0.12 0.25 0.19 0.19 0.18 0.20 0.24
Total Interest Expense		 0.46 0.49 0.49 1.19 1.73 2.09 4.29 1.60 1.19 1.25 1.26
Long-Term Debt Interest Expense		 0.46 0.49 0.49 1.19 1.73 2.09 4.29 1.60 1.19 1.25 1.26
Total Non-Interest Income		 47 75 80 105 81 84 109 123 117 92 123
Net Realized & Unrealized Capital Gains on Investments		 - - - - 0.00 0.45 7.71 - 0.39 0.40 0.00
Other Non-Interest Income		 47 75 80 105 81 84 101 113 116 91 123
Total Non-Interest Expense		 77 102 106 127 105 184 92 204 54 197 123
Marketing Expense		 16 15 19 18 17 15 16 16 15 11 14
Other Operating Expenses		 63 87 87 109 88 80 80 94 84 64 97
Impairment Charge		 - 0.05 0.42 - - 88 0.01 - - 1.36 0.04
Other Special Charges		 -0.88 -0.39 -0.53 -0.21 -0.44 0.68 -3.54 89 -45 120 13
Income Tax Expense		 0.00 0.00 0.00 0.01 0.00 0.00 0.00 - 0.00 0.22 0.74
Basic Earnings per Share		 ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.04 ($0.25) $0.19 ($0.33) $0.00
Weighted Average Basic Shares Outstanding		 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 320.55M 318.46M 323.43M 323.64M 323.76M
Diluted Earnings per Share		 ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.03 ($0.24) $0.05 ($0.33) $0.00
Weighted Average Diluted Shares Outstanding		 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 367.03M 318.46M 374.43M 323.64M 323.76M
Weighted Average Basic & Diluted Shares Outstanding		 309.43M 316.31M 316.53M 317.21M 317.20M 323.82M 323.82M 325.21M 325.34M 325.35M 328.18M

Annual Cash Flow Statements for Microvast

This table details how cash moves in and out of Microvast's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -44 -0.59 495 -233 -214 21
Net Cash From Operating Activities		 13 16 -45 -54 -75 2.81
Net Cash From Continuing Operating Activities		 13 16 -45 -54 -75 2.81
Net Income / (Loss) Continuing Operations		 -60 -34 -206 -158 -106 -195
Consolidated Net Income / (Loss)		 -60 -34 -206 -158 -106 -195
Provision For Loan Losses		 -0.02 1.10 19 1.64 0.24 3.74
Depreciation Expense		 15 16 20 20 22 30
Amortization Expense		 0.71 0.70 0.74 0.55 0.79 0.78
Non-Cash Adjustments to Reconcile Net Income		 5.95 4.25 146 113 86 216
Changes in Operating Assets and Liabilities, net		 52 27 -24 -30 -78 -53
Net Cash From Investing Activities		 -3.95 -18 -88 -176 -166 -12
Net Cash From Continuing Investing Activities		 -3.95 -18 -88 -176 -166 -12
Purchase of Property, Leasehold Improvements and Equipment		 -20 -19 -88 -151 -187 -28
Purchase of Investment Securities		 -20 -4.64 0.00 -25 -5.97 0.00
Sale of Property, Leasehold Improvements and Equipment		 0.02 0.01 0.00 0.01 1.65 10
Sale and/or Maturity of Investments		 37 5.59 0.00 0.00 26 5.56
Net Cash From Financing Activities		 -52 -0.51 625 4.97 33 38
Net Cash From Continuing Financing Activities		 -52 -0.51 625 4.97 33 38
Issuance of Debt		 82 36 105 59 48 127
Repayment of Debt		 -101 -37 -46 -54 -15 -67
Other Financing Activities, Net		 -33 0.00 566 0.00 0.00 -22
Effect of Exchange Rate Changes		 -0.99 2.04 2.87 -8.59 -6.56 -6.84
Cash Interest Paid		 2.49 1.97 2.69 5.14 4.37 7.44
Cash Income Taxes Paid		 0.06 0.00 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Microvast

This table details how cash moves in and out of Microvast's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Change in Cash & Equivalents		 -42 -90 -81 -1.02 -1.49 18 10 -5.37 13 16 3.81
Net Cash From Operating Activities		 -11 -30 -29 -4.95 2.03 0.11 -5.43 6.10 7.17 37 15
Net Cash From Continuing Operating Activities		 -11 -30 -29 -4.95 2.03 0.11 -5.43 6.10 7.17 37 15
Net Income / (Loss) Continuing Operations		 -30 -26 -26 -25 -25 -102 -9.87 -82 62 -106 -1.49
Consolidated Net Income / (Loss)		 -30 -26 -26 -25 -25 -102 -9.87 -82 62 -106 -1.49
Provision For Loan Losses		 -1.09 0.26 -0.21 1.27 0.58 0.18 -0.99 3.98 1.36 0.83 4.38
Depreciation Expense		 4.89 4.91 4.85 7.50 7.47 7.44 7.53 7.62 7.99 8.11 8.08
Amortization Expense		 0.21 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19
Non-Cash Adjustments to Reconcile Net Income		 22 23 21 21 16 108 35 81 -37 128 19
Changes in Operating Assets and Liabilities, net		 -7.52 -32 -29 -11 2.89 -14 -37 -4.29 -27 6.37 -15
Net Cash From Investing Activities		 -36 -58 -60 -12 -4.53 -2.92 -4.53 -0.18 -2.33 -2.75 -10
Net Cash From Continuing Investing Activities		 -36 -58 -60 -12 -4.53 -2.92 -4.53 -0.18 -2.33 -2.75 -10
Purchase of Property, Leasehold Improvements and Equipment		 -36 -58 -60 -33 -10 -2.95 -14 -0.36 -2.35 -2.86 -14
Sale of Property, Leasehold Improvements and Equipment		 0.34 0.31 0.23 0.77 0.15 0.03 9.65 0.18 0.01 0.12 3.61
Net Cash From Financing Activities		 4.38 0.91 6.86 21 6.26 22 18 -9.05 9.46 -16 -2.75
Net Cash From Continuing Financing Activities		 4.38 0.91 6.86 21 6.26 22 18 -9.05 9.46 -16 -2.75
Issuance of Debt		 4.38 4.85 9.21 29 19 34 43 31 28 31 10
Repayment of Debt		 0.00 -3.94 -2.35 -8.53 -13 -11 -8.38 -34 -14 -43 -9.78
Other Financing Activities, Net		 - - - - 0.00 - - -5.77 -4.29 -4.52 -3.44
Effect of Exchange Rate Changes		 0.47 -3.65 1.09 -4.47 -5.25 -1.64 2.30 -2.24 -0.91 -2.32 1.77

Annual Balance Sheets for Microvast

This table presents Microvast's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 0.10 280 405 995 985 1,097 952
Cash and Due from Banks		 0.02 0.14 21 481 231 45 73
Restricted Cash		 - - 20 55 71 44 37
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 - - 212 267 348 633 490
Intangible Assets		 - - 2.28 1.88 1.64 3.14 2.61
Other Assets		 0.00 0.26 149 190 333 373 350
Total Liabilities & Shareholders' Equity		 0.10 280 405 995 985 1,097 952
Total Liabilities		 0.08 0.70 389 309 372 533 564
Short-Term Debt		 - 0.00 121 115 131 254 187
Accrued Interest Payable		 - - - 59 67 149 99
Other Short-Term Payables		 0.00 0.27 63 1.53 54 0.00 44
Long-Term Debt		 0.08 0.00 73 73 73 87 189
Other Long-Term Liabilities		 - 0.43 132 60 47 42 45
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.03 5.00 -385 687 613 564 388
Total Preferred & Common Equity		 0.03 5.00 -385 687 613 564 388
Total Common Equity		 0.03 5.00 -385 687 613 564 388
Common Stock		 0.03 1.61 0.01 1,306 1,416 1,481 1,513
Retained Earnings		 -0.00 3.39 -398 -632 -791 -898 -1,093
Accumulated Other Comprehensive Income / (Loss)		 - - 7.36 6.70 -18 -26 -38
Other Equity Adjustments		 - - 6.03 6.03 6.03 6.03 6.03

Quarterly Balance Sheets for Microvast

This table presents Microvast's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 999 973 1,004 998 1,017 1,041 961 998 983 1,005 1,014
Cash and Due from Banks		 416 296 200 143 67 39 68 64 91 100 91
Restricted Cash		 55 83 60 28 22 45 35 40 32 39 52
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 285 299 456 510 561 628 508 516 497 533 535
Intangible Assets		 1.82 1.70 3.69 3.34 3.21 2.99 2.85 2.79 2.50 2.39 2.28
Other Assets		 241 294 284 314 363 325 348 375 361 330 333
Total Liabilities & Shareholders' Equity		 999 973 1,004 998 1,017 1,041 961 998 983 1,005 1,014
Total Liabilities		 341 357 398 418 449 495 506 512 529 649 655
Short-Term Debt		 117 116 131 123 159 187 188 188 191 423 395
Accrued Interest Payable		 61 80 94 117 122 138 143 105 105 102 129
Other Short-Term Payables		 3.60 36 53 53 54 41 41 43 44 0.00 5.68
Long-Term Debt		 73 82 73 75 75 86 91 121 144 76 76
Other Long-Term Liabilities		 87 43 47 50 38 42 43 55 45 48 49
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 657 616 606 580 567 546 455 486 454 356 358
Total Preferred & Common Equity		 657 616 604 578 565 546 455 486 454 356 358
Total Common Equity		 657 616 604 578 565 546 455 486 454 356 358
Common Stock		 1,320 1,398 1,434 1,452 1,468 1,493 1,506 1,512 1,514 1,515 1,515
Retained Earnings		 -677 -757 -821 -847 -873 -922 -1,024 -1,011 -1,031 -1,137 -1,139
Accumulated Other Comprehensive Income / (Loss)		 7.69 -31 -16 -34 -36 -31 -33 -22 -34 -27 -25
Other Equity Adjustments		 6.03 6.03 6.03 6.03 6.03 6.03 6.03 6.03 6.03 6.03 6.03

Annual Metrics And Ratios for Microvast

This table displays calculated financial ratios and metrics derived from Microvast's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 46.04% 49.62% 33.44% 50.52% 23.62%
EBITDA Growth		 0.00% 62.45% -1,003.30% 25.29% 40.35% -99.10%
EBIT Growth		 0.00% 44.16% -513.91% 22.92% 33.58% -85.08%
NOPAT Growth		 0.00% 44.16% -514.09% 23.40% 32.73% -83.70%
Net Income Growth		 0.00% 43.64% -514.08% 23.38% 32.74% -83.68%
EPS Growth		 0.00% 29.91% -53.66% 58.73% 34.62% -79.41%
Operating Cash Flow Growth		 0.00% 16.34% -389.53% -19.74% -39.64% 103.74%
Free Cash Flow Firm Growth		 0.00% 0.00% -1,815.58% 93.47% -208.86% 76.12%
Invested Capital Growth		 0.00% -25.29% 318.33% -6.61% 10.88% -10.80%
Revenue Q/Q Growth		 0.00% 0.00% 6.20% -6.38% 13.39% 4.93%
EBITDA Q/Q Growth		 0.00% 0.00% -12.58% 7.49% 13.94% -96.13%
EBIT Q/Q Growth		 0.00% 0.00% -11.74% 7.16% 9.04% -70.50%
NOPAT Q/Q Growth		 0.00% 0.00% -11.72% 7.76% 7.87% -70.56%
Net Income Q/Q Growth		 0.00% 0.00% -11.62% 7.56% 7.88% -70.54%
EPS Q/Q Growth		 0.00% 0.00% 29.21% -4.00% 5.56% -60.53%
Operating Cash Flow Q/Q Growth		 0.00% -23.32% -202.36% 31.72% -14.65% 134.15%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -9.37% -28.83% -139.63% 47.19%
Invested Capital Q/Q Growth		 0.00% -25.84% -2.09% 0.31% 12.98% 1.59%
Profitability Metrics		 - - - - - -
EBITDA Margin		 -63.96% -16.45% -121.27% -67.90% -26.91% -43.34%
EBIT Margin		 -85.92% -32.85% -134.79% -77.86% -34.36% -51.44%
Profit (Net Income) Margin		 -85.13% -32.85% -134.83% -77.42% -34.59% -51.40%
Tax Burden Percent		 100.32% 100.00% 100.00% 100.02% 100.01% 100.00%
Interest Burden Percent		 98.77% 100.00% 100.03% 99.41% 100.67% 99.92%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -15.06% -9.63% -26.68% -13.09% -8.65% -15.97%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -20.05% -59.15% -37.35% -20.36% -31.38%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -13.16% -32.14% -11.25% -9.43% -25.09%
Return on Equity (ROE)		 0.00% -22.79% -58.82% -24.34% -18.08% -41.06%
Cash Return on Invested Capital (CROIC)		 0.00% 19.32% -149.51% -6.26% -18.97% -4.55%
Operating Return on Assets (OROA)		 -42.92% -9.82% -29.49% -16.07% -10.15% -19.10%
Return on Assets (ROA)		 -42.53% -9.82% -29.50% -15.98% -10.22% -19.08%
Return on Common Equity (ROCE)		 0.00% 29.31% -25.31% -24.34% -18.08% -41.06%
Return on Equity Simple (ROE_SIMPLE)		 -1,193.26% 8.74% -30.07% -25.81% -18.86% -50.39%
Net Operating Profit after Tax (NOPAT)		 -42 -24 -145 -111 -74 -137
NOPAT Margin		 -60.14% -23.00% -94.38% -54.18% -24.21% -35.98%
Net Nonoperating Expense Percent (NNEP)		 0.00% 10.42% 32.47% 24.26% 11.72% 15.41%
SG&A Expenses to Revenue		 59.51% 29.70% 36.45% 32.36% 22.31% 16.74%
Operating Expenses to Revenue		 185.92% 132.85% 234.79% 177.86% 134.36% 151.44%
Earnings before Interest and Taxes (EBIT)		 -60 -34 -206 -159 -106 -196
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -45 -17 -186 -139 -83 -165
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 70.69 0.00 2.48 0.77 0.79 1.73
Price to Tangible Book Value (P/TBV)		 70.69 0.00 2.48 0.77 0.79 1.74
Price to Revenue (P/Rev)		 5.04 5.93 11.11 2.32 1.44 1.76
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.24 5.55 1.55 0.46 0.77 1.21
Enterprise Value to Revenue (EV/Rev)		 8.96 11.33 8.83 1.83 2.26 2.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 46.98 74.52 0.00 0.00 0.00 348.46
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 24.55 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 12.62 0.27 0.33 0.61 1.08
Long-Term Debt to Equity		 0.00 4.77 0.11 0.12 0.15 0.49
Financial Leverage		 0.00 0.66 0.54 0.30 0.46 0.80
Leverage Ratio		 1.00 2.32 1.99 1.52 1.77 2.15
Compound Leverage Factor		 0.99 2.32 1.99 1.51 1.78 2.15
Debt to Total Capital		 0.00% 92.66% 21.48% 24.94% 37.70% 51.98%
Short-Term Debt to Total Capital		 0.00% 57.67% 13.11% 16.02% 28.10% 28.60%
Long-Term Debt to Total Capital		 0.00% 34.99% 8.36% 8.92% 9.60% 23.38%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 98.21% 191.32% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 1.79% -183.98% 78.52% 75.06% 62.30% 48.02%
Debt to EBITDA		 0.00 -11.51 -1.01 -1.47 -4.13 -2.55
Net Debt to EBITDA		 0.00 -9.06 1.88 0.71 -3.06 -1.88
Long-Term Debt to EBITDA		 0.00 -4.35 -0.39 -0.53 -1.05 -1.15
Debt to NOPAT		 0.00 -8.23 -1.30 -1.84 -4.58 -3.07
Net Debt to NOPAT		 0.00 -6.48 2.41 0.89 -3.40 -2.27
Long-Term Debt to NOPAT		 0.00 -3.11 -0.51 -0.66 -1.17 -1.38
Noncontrolling Interest Sharing Ratio		 98.20% 228.61% 56.97% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 47 -810 -53 -163 -39
Operating Cash Flow to CapEx		 66.08% 83.49% -51.26% -35.74% -40.67% 15.88%
Free Cash Flow to Firm to Interest Expense		 0.00 8.23 -149.69 -15.92 -62.17 -4.02
Operating Cash Flow to Interest Expense		 2.11 2.71 -8.32 -16.23 -28.65 0.29
Operating Cash Flow Less CapEx to Interest Expense		 -1.08 -0.54 -24.56 -61.63 -99.10 -1.53
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.50 0.30 0.22 0.21 0.30 0.37
Fixed Asset Turnover		 0.00 0.00 0.64 0.66 0.63 0.68
Capital & Investment Metrics		 - - - - - -
Invested Capital		 280 209 875 817 906 808
Invested Capital Turnover		 0.25 0.42 0.28 0.24 0.36 0.44
Increase / (Decrease) in Invested Capital		 0.00 -71 665 -58 89 -98
Enterprise Value (EV)		 628 1,159 1,353 375 696 981
Market Capitalization		 353 607 1,701 473 443 670
Book Value per Share		 $0.14 ($10.84) $2.29 $1.98 $1.78 $1.20
Tangible Book Value per Share		 $0.14 ($10.90) $2.28 $1.98 $1.77 $1.19
Total Capital		 280 209 875 817 906 808
Total Debt		 0.00 194 188 204 341 420
Total Long-Term Debt		 0.00 73 73 73 87 189
Net Debt		 -0.14 153 -348 -98 253 310
Capital Expenditures (CapEx)		 20 19 88 151 185 18
Net Nonoperating Expense (NNE)		 18 10 62 47 32 59
Net Nonoperating Obligations (NNO)		 0.00 194 188 204 341 420
Total Depreciation and Amortization (D&A)		 15 17 21 20 23 31
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.26) ($0.52) ($0.34) ($0.61)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 300.53M 303.28M 310.91M 318.46M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.26) ($0.52) ($0.34) ($0.61)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 300.53M 303.28M 310.91M 318.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($1.26) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 185.90M 309.41M 317.21M 325.21M
Normalized Net Operating Profit after Tax (NOPAT)		 -44 -26 -139 -111 -76 -17
Normalized NOPAT Margin		 -63.38% -25.49% -91.01% -54.47% -24.56% -4.60%
Pre Tax Income Margin		 -84.86% -32.85% -134.83% -77.40% -34.59% -51.40%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 -9.48 -5.86 -38.15 -47.88 -40.22 -20.14
NOPAT to Interest Expense		 -6.64 -4.10 -26.71 -33.32 -28.34 -14.09
EBIT Less CapEx to Interest Expense		 -12.67 -9.11 -54.39 -93.29 -110.67 -21.97
NOPAT Less CapEx to Interest Expense		 -9.82 -7.35 -42.95 -78.72 -98.79 -15.91
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Microvast

This table displays calculated financial ratios and metrics derived from Microvast's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 32.36% 18.84% 107.19% 58.00% 66.49% 7.69% 21.29% 17.27% 45.31% 10.23% 16.45%
EBITDA Growth		 36.14% 46.17% 33.18% 45.76% 29.88% -347.69% 199.24% -361.61% 507.71% -3.85% -64.13%
EBIT Growth		 32.45% 40.98% 28.38% 31.04% 16.05% -289.43% 150.62% -245.56% 348.90% -4.22% -105.66%
NOPAT Growth		 32.45% 40.98% 28.38% 26.98% 16.05% -289.43% 172.31% -234.91% 455.57% -4.22% -103.96%
Net Income Growth		 32.45% 40.98% 28.38% 27.03% 16.05% -289.43% 150.62% -234.77% 348.90% -4.43% -111.24%
EPS Growth		 33.33% 46.67% 33.33% 20.00% 20.00% -300.00% 137.50% -200.00% 162.50% -3.13% -100.00%
Operating Cash Flow Growth		 55.18% 22.73% -693.97% -206.13% 118.19% 100.37% 81.50% 223.18% 252.98% 33,372.07% 379.30%
Free Cash Flow Firm Growth		 102.80% 109.45% -110.60% -409.73% -263.55% -148.60% 446.47% 137.88% 436.86% -598.10% -275.64%
Invested Capital Growth		 -4.42% -8.87% -1.56% 10.88% 1.24% -5.56% -0.79% -10.80% -3.74% 16.42% 4.27%
Revenue Q/Q Growth		 -28.71% 58.65% 5.56% 29.06% -22.97% 2.62% 18.89% 24.78% -4.55% -21.73% 34.82%
EBITDA Q/Q Growth		 17.94% 14.28% -1.91% 23.45% -4.52% -447.29% 129.37% -456.06% 193.70% -239.41% 107.71%
EBIT Q/Q Growth		 14.56% 11.81% -1.30% 8.80% -2.96% -309.09% 116.76% -722.62% 174.92% -271.29% 99.29%
NOPAT Q/Q Growth		 12.16% 11.81% -0.36% 6.08% -0.99% -309.09% 124.13% -535.01% 207.23% -219.90% 99.29%
Net Income Q/Q Growth		 12.25% 11.81% -0.36% 6.04% -0.95% -309.09% 116.89% -721.45% 175.06% -271.64% 98.60%
EPS Q/Q Growth		 0.00% 20.00% 0.00% 0.00% 0.00% -300.00% 112.00% -900.00% 120.83% -760.00% 100.00%
Operating Cash Flow Q/Q Growth		 -339.25% -167.26% 1.68% 83.12% 141.01% -94.53% -4,990.99% 212.38% 17.51% 418.26% -59.19%
Free Cash Flow Firm Q/Q Growth		 -51.01% 241.85% -109.87% -1,774.75% 56.45% -1.59% 156.32% 104.95% 130.04% -310.53% 82.30%
Invested Capital Q/Q Growth		 -0.85% -4.02% 3.13% 12.98% -4.95% -10.47% 5.03% 1.59% -2.31% 8.28% -2.98%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 -51.10% -27.61% -26.35% -15.63% -21.52% -114.78% 21.56% -61.51% 60.38% -107.56% 6.15%
EBIT Margin		 -61.74% -34.32% -32.63% -23.06% -31.13% -124.11% 13.62% -67.95% 53.33% -116.71% -0.61%
Profit (Net Income) Margin		 -61.74% -34.32% -32.63% -23.76% -31.13% -124.11% 13.62% -67.82% 53.33% -116.95% -1.22%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.04% 100.00% 100.00% 100.00% 100.00% 100.00% 100.21% 198.53%
Interest Burden Percent		 100.00% 100.00% 100.00% 102.99% 100.00% 100.00% 100.00% 99.81% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -11.36% -6.77% -7.67% -5.94% -9.08% -39.70% 6.18% -21.07% 27.60% -43.69% -0.23%
ROIC Less NNEP Spread (ROIC-NNEP)		 -15.86% -10.72% -11.30% -8.65% -12.20% -52.49% 6.18% -27.56% 27.60% -51.92% -0.48%
Return on Net Nonoperating Assets (RNNOA)		 -4.94% -3.44% -4.13% -4.00% -5.06% -24.17% 3.19% -22.04% 16.79% -49.76% -0.44%
Return on Equity (ROE)		 -16.30% -10.22% -11.80% -9.94% -14.14% -63.87% 9.37% -43.11% 44.39% -93.45% -0.68%
Cash Return on Invested Capital (CROIC)		 -7.64% -1.53% -8.44% -18.97% -9.97% -10.69% -9.25% -4.55% -5.66% -25.15% -15.13%
Operating Return on Assets (OROA)		 -13.43% -8.01% -8.90% -6.81% -10.34% -43.75% 4.90% -25.22% 21.95% -50.43% -0.27%
Return on Assets (ROA)		 -13.43% -8.01% -8.90% -7.02% -10.34% -43.75% 4.90% -25.18% 21.95% -50.53% -0.54%
Return on Common Equity (ROCE)		 -16.28% -10.20% -11.78% -9.94% -14.11% -63.75% 9.35% -43.11% 44.39% -93.45% -0.68%
Return on Equity Simple (ROE_SIMPLE)		 -23.85% -21.79% -20.43% 0.00% -18.62% -38.93% -23.58% 0.00% -23.96% -31.83% -35.77%
Net Operating Profit after Tax (NOPAT)		 -21 -18 -18 -17 -17 -71 13 -58 62 -74 -0.53
NOPAT Margin		 -43.22% -24.02% -22.84% -16.62% -21.79% -86.88% 13.62% -47.47% 53.33% -81.69% -0.43%
Net Nonoperating Expense Percent (NNEP)		 4.51% 3.95% 3.63% 2.71% 3.12% 12.79% 0.00% 6.49% 0.00% 8.23% 0.25%
SG&A Expenses to Revenue		 33.09% 20.27% 24.03% 17.48% 21.42% 18.49% 16.09% 12.99% 12.99% 12.29% 11.26%
Operating Expenses to Revenue		 161.74% 134.32% 132.63% 123.06% 131.13% 224.11% 86.38% 167.95% 46.67% 216.71% 100.61%
Earnings before Interest and Taxes (EBIT)		 -30 -26 -26 -24 -25 -102 13 -82 62 -106 -0.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -24 -21 -21 -16 -17 -94 21 -75 70 -98 7.52
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.64 0.86 1.06 0.79 0.49 0.32 0.17 1.73 0.84 3.32 3.50
Price to Tangible Book Value (P/TBV)		 0.64 0.86 1.06 0.79 0.49 0.32 0.17 1.74 0.84 3.34 3.52
Price to Revenue (P/Rev)		 1.76 2.15 2.20 1.44 0.78 0.42 0.22 1.76 0.91 2.78 2.83
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.41 0.67 0.93 0.77 0.55 0.44 0.36 1.21 0.75 1.80 1.91
Enterprise Value to Revenue (EV/Rev)		 1.51 2.28 2.75 2.26 1.34 0.93 0.79 2.58 1.42 3.63 3.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 348.46 74.50 34.24 24.10
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.34 0.34 0.41 0.61 0.50 0.61 0.64 1.08 0.74 1.40 1.32
Long-Term Debt to Equity		 0.12 0.13 0.13 0.15 0.16 0.20 0.25 0.49 0.32 0.21 0.21
Financial Leverage		 0.31 0.32 0.37 0.46 0.41 0.46 0.52 0.80 0.61 0.96 0.92
Leverage Ratio		 1.59 1.60 1.68 1.77 1.77 1.89 1.91 2.15 2.02 2.42 2.38
Compound Leverage Factor		 1.59 1.60 1.68 1.82 1.77 1.89 1.91 2.15 2.02 2.42 2.38
Debt to Total Capital		 25.18% 25.41% 29.22% 37.70% 33.38% 38.01% 38.87% 51.98% 42.44% 58.32% 56.81%
Short-Term Debt to Total Capital		 16.16% 15.77% 19.89% 28.10% 22.87% 25.66% 23.65% 28.60% 24.19% 49.44% 47.63%
Long-Term Debt to Total Capital		 9.02% 9.64% 9.32% 9.60% 10.51% 12.35% 15.21% 23.38% 18.25% 8.88% 9.18%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.27% 0.26% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 74.55% 74.33% 70.54% 62.30% 66.62% 61.99% 61.13% 48.02% 57.56% 41.68% 43.20%
Debt to EBITDA		 -1.63 -1.85 -2.44 -4.13 -3.63 -1.88 -3.68 -2.55 -4.31 -6.13 -4.97
Net Debt to EBITDA		 0.45 -0.25 -1.51 -3.06 -2.51 -1.19 -2.44 -1.88 -2.73 -4.42 -3.47
Long-Term Debt to EBITDA		 -0.58 -0.70 -0.78 -1.05 -1.14 -0.61 -1.44 -1.15 -1.85 -0.93 -0.80
Debt to NOPAT		 -2.02 -2.24 -2.90 -4.58 -3.85 -2.25 -3.85 -3.07 -4.40 -6.29 -5.29
Net Debt to NOPAT		 0.56 -0.31 -1.79 -3.40 -2.66 -1.42 -2.56 -2.27 -2.78 -4.54 -3.69
Long-Term Debt to NOPAT		 -0.72 -0.85 -0.92 -1.17 -1.21 -0.73 -1.51 -1.38 -1.89 -0.96 -0.86
Noncontrolling Interest Sharing Ratio		 0.17% 0.17% 0.17% 0.00% 0.19% 0.20% 0.19% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 17 57 -5.66 -106 -27 -28 20 40 92 -195 -34
Operating Cash Flow to CapEx		 -31.38% -51.99% -49.14% -15.27% 20.13% 3.81% -119.85% 3,389.44% 307.42% 1,353.02% 146.12%
Free Cash Flow to Firm to Interest Expense		 36.56 117.79 -11.53 -89.08 -15.85 -13.31 4.57 25.19 77.82 -155.45 -27.44
Operating Cash Flow to Interest Expense		 -24.33 -61.28 -59.76 -4.16 1.17 0.05 -1.27 3.83 6.03 29.68 12.08
Operating Cash Flow Less CapEx to Interest Expense		 -101.85 -179.14 -181.37 -31.40 -4.65 -1.34 -2.32 3.71 4.07 27.48 3.81
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.22 0.23 0.27 0.30 0.33 0.35 0.36 0.37 0.41 0.43 0.44
Fixed Asset Turnover		 0.59 0.56 0.63 0.63 0.63 0.68 0.67 0.68 0.74 0.82 0.84
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 810 777 802 906 820 734 795 808 789 855 829
Invested Capital Turnover		 0.26 0.28 0.34 0.36 0.42 0.46 0.45 0.44 0.52 0.53 0.54
Increase / (Decrease) in Invested Capital		 -37 -76 -13 89 10 -43 -6.36 -98 -31 121 34
Enterprise Value (EV)		 329 524 745 696 454 321 286 981 592 1,541 1,581
Market Capitalization		 384 495 598 443 265 145 81 670 380 1,181 1,253
Book Value per Share		 $1.95 $1.87 $1.79 $1.78 $1.73 $1.43 $1.50 $1.20 $1.40 $1.09 $1.10
Tangible Book Value per Share		 $1.94 $1.86 $1.78 $1.77 $1.72 $1.43 $1.49 $1.19 $1.40 $1.09 $1.09
Total Capital		 810 777 802 906 820 734 795 808 789 855 829
Total Debt		 204 197 234 341 274 279 309 420 335 498 471
Total Long-Term Debt		 73 75 75 87 86 91 121 189 144 76 76
Net Debt		 -57 27 145 253 190 176 205 310 212 360 328
Capital Expenditures (CapEx)		 36 57 60 32 10 2.92 4.53 0.18 2.33 2.75 10
Net Nonoperating Expense (NNE)		 8.87 7.82 7.85 7.38 7.45 30 0.00 25 0.00 32 0.96
Net Nonoperating Obligations (NNO)		 204 197 234 341 274 279 309 420 335 498 471
Total Depreciation and Amortization (D&A)		 5.10 5.10 5.04 7.69 7.66 7.64 7.72 7.81 8.18 8.30 8.27
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.04 ($0.25) $0.19 ($0.33) $0.00
Adjusted Weighted Average Basic Shares Outstanding		 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 320.55M 318.46M 323.43M 323.64M 323.76M
Adjusted Diluted Earnings per Share		 ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.03 ($0.24) $0.05 ($0.33) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 367.03M 318.46M 374.43M 323.64M 323.76M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 309.43M 316.31M 316.53M 317.21M 317.20M 323.82M 323.82M 325.21M 325.34M 325.35M 328.18M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -18 -18 -17 -18 -9.31 1.41 4.50 12 11 8.38
Normalized NOPAT Margin		 -44.51% -24.34% -22.93% -16.76% -22.18% -11.38% 1.45% 3.71% 10.21% 12.30% 6.85%
Pre Tax Income Margin		 -61.74% -34.32% -32.63% -23.75% -31.13% -124.11% 13.62% -67.82% 53.33% -116.71% -0.61%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -64.42 -53.55 -53.30 -20.04 -14.33 -48.50 3.09 -51.71 52.01 -84.54 -0.60
NOPAT to Interest Expense		 -45.10 -37.48 -37.31 -14.45 -10.03 -33.95 3.09 -36.13 52.01 -59.17 -0.42
EBIT Less CapEx to Interest Expense		 -141.95 -171.41 -174.92 -47.28 -20.16 -49.89 2.03 -51.82 50.05 -86.73 -8.87
NOPAT Less CapEx to Interest Expense		 -122.62 -155.35 -158.93 -41.69 -15.86 -35.34 2.03 -36.24 50.05 -61.37 -8.69
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Microvast’s recent financial trend is a mixed picture: revenue has generally held up, cash flow turned positive in 2025, but the company is still carrying heavy debt and remains unprofitable. Compared with 2024, Q3 2025 showed improvement in operating cash generation and a much smaller loss, but the balance sheet is still leveraged and equity remains supported by large accumulated losses.

  • Q3 2025 operating cash flow was positive at $15.2 million, a notable improvement from Q2 2025 ($37.2 million) after a weak Q4 2024 and mixed 2024 performance.
  • Cash and cash equivalents rose to $90.7 million in Q3 2025, up from $99.7 million in Q2 2025 but still comfortably above the lows seen in late 2023 and early 2024.
  • Total assets increased to $1.01 billion in Q3 2025, reflecting a stable asset base with a large investment in premises and equipment.
  • Revenue in Q3 2025 came in at $122.3 million, above Q2 2025’s $90.7 million and Q1 2025’s $115.9 million, suggesting business activity remains resilient.
  • Net loss narrowed sharply in Q3 2025 to $1.5 million, versus a $106.1 million loss in Q2 2025 and a $82.3 million loss in Q4 2024.
  • Debt balances trended down versus early 2025, with short-term debt at $394.9 million and long-term debt at $76.1 million in Q3 2025, both below Q1 2025 levels.
  • Microvast continues to rely heavily on non-interest income, which made up the bulk of revenue in recent quarters, so earnings can be sensitive to one-time or non-core items.
  • Depreciation remains significant, with Q3 2025 depreciation of $8.1 million, reflecting a capital-intensive manufacturing footprint.
  • Equity improved modestly to $358.1 million in Q3 2025, but retained earnings remain deeply negative at $1.14 billion, showing the company is still recovering from years of losses.
  • Quarterly revenue has been fairly steady in the $90 million to $122 million range in 2025, indicating stability, but not yet a clear acceleration trend.
  • The company remains unprofitable on a quarterly basis, even after the Q3 2025 improvement.
  • Total liabilities were $655.5 million in Q3 2025, leaving leverage elevated relative to equity.
  • Interest costs are still a burden, with Q3 2025 interest expense of $1.3 million and a negative net interest result.
  • Other operating expenses remained large, with Q3 2025 other operating expenses of $96.5 million and special charges of $12.7 million, showing a high cost structure.
  • Historical cash flow was volatile, with some quarters in 2023 and 2024 showing negative operating cash flow, which raises execution risk if profitability does not improve consistently.

Bottom line: Microvast appears to be moving in the right direction operationally, with better cash generation and a smaller loss in Q3 2025. However, investors should still watch the company’s debt load, reliance on non-core income, and whether it can sustain positive operating cash flow over multiple quarters.

06/15/26 07:37 AM ETAI Generated. May Contain Errors.

Microvast Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Microvast's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Microvast's net income appears to be on an upward trend, with a most recent value of -$195.46 million in 2024, rising from -$59.66 million in 2019. The previous period was -$106.41 million in 2023.

Over the last 5 years, Microvast's total revenue changed from $70.08 million in 2019 to $380.24 million in 2024, a change of 442.6%.

Microvast's total liabilities were at $563.97 million at the end of 2024, a 5.9% increase from 2023, and a 744,004.9% increase since 2018.

In the past 6 years, Microvast's cash and equivalents has ranged from $17.50 thousand in 2018 to $480.93 million in 2021, and is currently $73.01 million as of their latest financial filing in 2024.

Over the last 5 years, Microvast's book value per share changed from 0.14 in 2019 to 1.20 in 2024, a change of 750.2%.


Related Companies

Financial statements for NASDAQ:MVSTW last updated on 11/24/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel